Oleic acid produced by a marine Vibrio spp. acts as an anti-Vibrio parahaemolyticus agent

Anti-Vibrio potential of natural products from marine microorganisms

The emergence of drug-resistant Vibrio poses a serious threat to aquaculture and human health, thus there is an urgent need for the discovery of new related antibiotics. Given that marine microorganisms (MMs) are evidenced as important sources of antibacterial natural products (NPs), great attention has been gained to the exploration of potential anti-Vibrio agents from MMs. This review summarizes the occurrence, structural diversity, and biological activities of 214 anti-Vibrio NPs isolated from MMs (from 1999 to July 2022), including 108 new compounds. They were predominantly originated from marine fungi (63%) and bacteria (30%) with great structural diversity, including polyketides, nitrogenous compounds, terpenoids, and steroids, among which polyketides account for nearly half (51%) of them. This review will shed light on the development of MMs derived NPs as potential anti-Vibrio lead compounds with promising applications in agriculture and human health.

Natural products as antivibrio agents: insight into the chemistry and biological activity

Vibriosis causes serious problems and economic loss in aquaculture and human health. Investigating natural products as antivibrio agents has gained more attention to combat vibriosis. The present review highlights the chemical diversity of antivibrio isolated from bacteria, fungi, plants, and marine organisms. Based on the study covering the literature from 1985-2021, the chemical diversity ranges from alkaloids, terpenoids, polyketides, sterols, and peptides. The mechanisms of action are included inhibiting growth, interfering with biofilm formation, and disrupting of quorum sensing. Relevant summaries focusing on the source organisms and the associated bioactivity of different chemical classes are also provided. Further research on in vivo studies, toxicity, and clinical is required for the application in aquaculture and human health.

Efficacy of Ethanolic Extract of Syzygium aromaticum in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates Associated with Urinary Tract Infections

Pseudomonas aeruginosa is an organism commonly found in the environment and one of the most common causes of human urinary tract infections in developed and developing countries. The present study aimed to investigate the effect of five medicinal plant extracts on the isolated drug-resistant P. aeruginosa clinical isolates. A total of 100 urine samples were collected from Nagaa Hammadi and Qena General Hospitals and private medical analysis laboratories in Qena governorate, Upper Egypt. Samples were screened for the prevalence of UTI pathogens by biochemical tests, antibiotics sensitivity, detection of virulence, and antibiotic-resistant genes by using multiplex PCR. P. aeruginosa is by far the subdominant causative agent with a percentage of 14%. Clinical isolates were multidrug-resistant, containing bla TEM, bla SHV, toxA, lasB, pslA, and fliC resistant and virulence genes. Based on bioactivity, the ethanolic extract of clove (Syzygium aromaticum) was the most active extract among tested medicinal plants and had the maximum zone of inhibition sized 23 mm against tested bacteria. The results of the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) showed a high decrease of inhibition within a concentration range of (10 to 121.25 mg/mL and 20 to 30 mg/mL, respectively). Further, major compounds of oleic acid (27.22%), guanosine (8.91%), indole (6.83%), 1-eicosene (6.30%), and cis-10-nonadecenoic acid (5.37%) were determined among 12 bioactive compounds in the ethanolic extract of S. aromaticum using gas chromatography-mass spectrometry (GC-MS). These results indicated that the ethanolic extract of S. aromaticum is a promising antibacterial agent for further studies aiming to control bacterial infections including MDR bacteria and develop novel therapeutic alternatives for the treatment of UTI.

Saccharothrix sp. TD-093 from the Thar Desert, India: Metabolite Fingerprinting of Antimicrobial Compounds and in silico Analysis

During a screening program for actinomycetes from underexplored and arid Thar Desert (India), TD-093 was isolated. The isolate was characterized based on 16S rDNA sequencing. Aqueous and organic solvent extracts of culture supernatant were investigated for antimicrobial activity. Bioactive fractions, after column chromatography separation, were subjected to GC-MS analysis. Based on 16S rDNA sequence result, isolate TD-093 showed nearest match to Saccharothrix (96%) and is a potential new species. Aqueous and organic solvent extracts showed antimicrobial activity against Staphylococcus epidermidis, Micrococcus luteus, Pseudomonas fluorescens, and Escherichia coli as well as clinical isolates (Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Acinetobacter baumannii). GC-MS metabolite fingerprinting resulted in 32 compounds belonging to fatty acid, hydrocarbon, alcohol, aldehyde, amide, ester, ketone, disulfide, and nitrile chemical groups. Combination analyses of the compounds based on retention time, similarity index, mass ion spectra, and retention indices-observed and calculated, showed that many of the compounds could be presumed to be novel. Further, four compounds showed retention indices that have not been documented in databases. In silico analysis (using software Prediction of Activity of Spectra for Substances) of compounds predicted by GC-MS data showed that 21 compounds had potential antibacterial activity.